NMTC · NEUROONE MEDICAL TECHNOLOGIES Corp
$1.63
-0.04 (-2.40%)
At close · Jul 29
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 12, 2026
Market Cap
$14.36M
Shares
8.70M
NEUROONE MEDICAL TECHNOLOGIES Corp Earnings Call Transcripts
Every quarterly earnings call for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼48.8%
$36,584
−$3.06M
'22 Q1
22-02-14
▼20.1%
$32,049
−$2.76M
'22 Q3
22-08-11
▲213.2%
$114,579
−$1.73M
'23 Q1
23-02-14
·
$466,176
−$3.52M
'23 Q2
23-05-11
▲1865.4%
$629,906
−$3.47M
'23 Q3
23-08-14
▲753.3%
$977,649
−$3.34M
'24 Q1
24-02-13
▲195.4%
$1.38M
−$2.86M
'24 Q2
24-05-14
▲31.1%
$825,776
−$2.77M
'24 Q3
24-08-14
▼63.3%
$272,284
−$3.35M
'24 Q4
24-12-17
▲234.9%
$3.27M
$1.79M
'25 Q1
25-02-12
▲0.7%
$1.39M
−$2.27M
'25 Q2
25-05-13
▲105.4%
$1.70M
−$1.50M
'25 Q3
25-08-14
▲906.6%
$2.74M
−$1.62M
'25 Q4
25-12-17
▼11.7%
$2.89M
−$1.44M
'26 Q1
26-02-17
LATEST
▲34.3%
$1.86M
−$2.38M
'26 Q2
26-05-12
Earnings call
FY26 · Q2
2026-05-12
NEUROONE MEDICAL TECHNOLOGIES Corp Q2 FY2026 Earnings Call
Confident tone
Trigeminal Nerve Ablation System
International Expansion / ISO 13485
1RF Brain Ablation Revenue Growth
Revenue
$1.86M
▲ 34.3% YoY Diluted EPS
$-0.28
Gross margin
53.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-02-17
NEUROONE MEDICAL TECHNOLOGIES Corp Q1 FY2026 Earnings Call
Revenue
$2.89M
▼ 11.7% YoY Diluted EPS
$-0.18
▼ 150% YoY Gross margin
54.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-12-17
NEUROONE MEDICAL TECHNOLOGIES Corp Q4 FY2025 Earnings Call
Revenue
$2.74M*
▲ 906.6% YoY Gross margin
55.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-08-14
NEUROONE MEDICAL TECHNOLOGIES Corp Q3 FY2025 Earnings Call
Revenue
$1.70M
▲ 105.4% YoY Diluted EPS
$-0.18
Gross margin
53.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-05-13
NEUROONE MEDICAL TECHNOLOGIES Corp Q2 FY2025 Earnings Call
Revenue
$1.39M
▲ 0.7% YoY Diluted EPS
$-0.44
Gross margin
55.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-02-12
NEUROONE MEDICAL TECHNOLOGIES Corp Q1 FY2025 Earnings Call
Confident tone
OneRF Ablation System Commercialization & Clinical Results
Revenue & Gross Margin Growth
Zimmer Biomet Partnership
Revenue
$3.27M
▲ 234.9% YoY Diluted EPS
$0.36
Gross margin
58.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-12-17
NEUROONE MEDICAL TECHNOLOGIES Corp Q4 FY2024 Earnings Call
Revenue
$272,284*
▼ 63.3% YoY Gross margin
51.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-08-14
NEUROONE MEDICAL TECHNOLOGIES Corp Q3 FY2024 Earnings Call
Confident tone
Revenue and Operating Results
OneRF Ablation System Commercial Launch
Capital and Balance Sheet
Revenue
$825,776
▲ 31.1% YoY Diluted EPS
$-0.60
Gross margin
34.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-05-14
NEUROONE MEDICAL TECHNOLOGIES Corp Q2 FY2024 Earnings Call
Revenue
$1.38M
▲ 195.4% YoY Diluted EPS
$-0.66
Gross margin
28.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-02-13
NEUROONE MEDICAL TECHNOLOGIES Corp Q1 FY2024 Earnings Call
Revenue
$977,649
▲ 753.3% YoY Diluted EPS
$-0.84
Gross margin
27.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q3
2023-08-14
NEUROONE MEDICAL TECHNOLOGIES Corp Q3 FY2023 Earnings Call
Revenue
$629,906
▲ 1865.4% YoY Diluted EPS
$-1.20
Gross margin
38.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-05-11
NEUROONE MEDICAL TECHNOLOGIES Corp Q2 FY2023 Earnings Call
Revenue
$466,176
Diluted EPS
$-1.26
Gross margin
6.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-02-14
NEUROONE MEDICAL TECHNOLOGIES Corp Q1 FY2023 Earnings Call
Revenue
$114,579
▲ 213.2% YoY Diluted EPS
$-0.66
Gross margin
-10.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q3
2022-08-11
NEUROONE MEDICAL TECHNOLOGIES Corp Q3 FY2022 Earnings Call
Revenue
$32,049
▼ 20.1% YoY Diluted EPS
$-1.02
Gross margin
-20.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-05-12
NEUROONE MEDICAL TECHNOLOGIES Corp Q2 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-02-14
NEUROONE MEDICAL TECHNOLOGIES Corp Q1 FY2022 Earnings Call
Revenue
$36,584
▼ 48.8% YoY Gross margin
-99.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-12-15
NEUROONE MEDICAL TECHNOLOGIES Corp Q4 FY2021 Earnings Call
Revenue
$48,336*
Gross margin
-35.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-08-13
NEUROONE MEDICAL TECHNOLOGIES Corp Q3 FY2021 Earnings Call
Revenue
$40,096
Gross margin
-54.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–18 of 18 earnings calls